APRIL RUBENSTRUNK: Open Payments
NPI 1659483279 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 39 payments from 15 companies in 2025. Trend: 2023 $834 · 2024 $646 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $142 |
| Alnylam Pharmaceuticals Inc. | 5 | $139 |
| Merck Sharp & Dohme LLC | 5 | $114 |
| PFIZER INC. | 5 | $91 |
| Amgen Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Abbott Laboratories | 3 | $56 |
| SCPHARMACEUTICALS INC. | 2 | $48 |
| BridgeBio Pharma, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: ONPATTRO, VERQUVO, REPATHA, LEQVIO, VYNDAQEL, FUROSCIX, Attruby, JARDIANCE.
Industry payments across FL — which companies pay providers there.
